On February 22, 2021 Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, reported the company will participate at the Cowen 41st Annual Virtual Health Care Conference, H.C. Wainwright Global Life Sciences Conference, and Oppenheimer 31st Annual Virtual Healthcare Conference (Press release, Alpine Immune Sciences, FEB 22, 2021, View Source [SID1234575396]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Virtual Health Care Conference
Date: Monday, March 1, 2021
Time: 10:20 a.m. ET/7:20 a.m. PT
Event: Novel IO Panel

H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time: Available on demand beginning 7:00 a.m. ET/4:00 a.m. PT
Event: Company Presentation

Oppenheimer 31st Annual Virtual Healthcare Conference
Date: Wednesday, March 17, 2021
Time: 1:50 p.m. ET/10:50 a.m. PT
Event: Company Presentation

A webcast of the H.C. Wainwright and Oppenheimer presentations will be available online in the investor relations section of the company’s website at View Source A replay of the presentations will be available on the company website for 90 days following the webcast.